CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Returned to the company President and CEO returned 10,000 shares (to the company)
- 4 Grant or award Senior VP of Marketing acquired 5,531 shares (grant or award)
- 4 Grant or award VP, Legal and Secretary acquired 3,934 shares (grant or award)
- 4 Grant or award Sr VP, CFO, Treasr, Asst Secy acquired 3,934 shares (grant or award)
- 4 Grant or award SVP and Chief Medical Officer acquired 3,934 shares (grant or award)
- 4 Open-market buy SVP and Chief Medical Officer bought 12,000 shares at $1.88 ($22,560)
- 4 Returned to the company President and CEO returned 10,000 shares (to the company)
- 4 Open-market buy Director bought 110,557 shares at $1.75 ($193,475)
- 4 Returned to the company President and CEO returned 10,000 shares (to the company)
- 4 Open-market buy Sr VP, CFO, Treasr, Asst Secy bought 295 shares at $1.69 ($499)
- 4 Grant or award Director acquired 53,312 shares (grant or award)
- 4 Returned to the company President and CEO returned 10,000 shares (to the company)
- 4 Returned to the company President and CEO returned 10,000 shares (to the company)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 14 of 20 · 382 filings